1887

Journal of Medical Microbiology logo

Volume 70, Issue 3

Implication of efflux pumps and genes in resistance of clinical isolates to fluconazole Free

Abstract

has been recognized as an opportunistic agent having a limited sensitivity to antifungal treatment.

Molecular mechanisms of azole resistance have been rarely reported for . Similar to other fungi, we hypothesized that both gene mutation and efflux pumps genes hyper-expression were implicated.

The current work aimed to study the sensitivity of clinical isolates to different antifungal agents and to explore their resistance mechanisms by molecular methods including real-time PCR and gene sequencing.

The sensitivity of isolates to fluconazole, amphotericin B and voriconazole was estimated by the Etest method. Real-time PCR was used to measure the relative expression of and genes via the housekeeping gene. Three pairs of primers were also chosen to sequence the gene. This exploration was followed by statistical study including the receiver operating characteristic (ROC) curve analysis to identify a relationship between gene mean expression and the sensitivity of isolates.

In 31 clinical isolates, the resistance frequencies were 87, 16.1 and 3.2 %, respectively, for amphotericin B, fluconazole and voriconazole. Quantitative real-time PCR demonstrated that only over-expression was significantly associated with FCZ resistance confirmed by univariate statistical study and the ROC curve analysis ( <0.05). The sequencing revealed two mutations H380G and S381A in TN325U11 (MIC FCZ=8 µg ml) and H437R in TN114U09 (MIC FCZ=256 µg ml) in highly conserved regions (close to the haem-binding domain) but their involvement in the resistance mechanism has not yet been assigned.

FCZ resistance mechanisms are proven to be much more complex and gene alteration sequence and/or expression can be involved. Only gene over-expression was significantly associated with FCZ resistance and no good correlation was observed between FCZ and VCZ MIC values and relative gene expression. sequence alteration seems to play a major role in FCZ resistance mechanism but their involvement needs further confirmation.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): fluconazole susceptibility , resistance mechanisms and Trichosporon asahii
© 2021 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001236
2021-03-10
2024-05-05
Loading full text...

Full text loading...

/deliver/fulltext/jmm/70/3/jmm001236.html?itemId=/content/journal/jmm/10.1099/jmm.0.001236&mimeType=html&fmt=ahah

References

  1. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 2005; 116:61–67 [View Article][PubMed]
     [Google Scholar]
  2. Abdallah Y, Kaddu-Mulindwa D, Nankunda J, Musoke PM. Prevalence and immediate outcome of Candida colonized preterm neonates admitted to special care unit of Mulago Hospital, Kampala Uganda. Afr Health Sci 2015; 15:197–205 [View Article][PubMed]
     [Google Scholar]
  3. Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43:1818–1828 [View Article][PubMed]
     [Google Scholar]
  4. Ruan Sheng‐Yuan, Chien Jung‐Yien, Hsueh Po‐Ren, Ruan S-Y, Chien J-Y, Hsueh P-R. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Diseases 2009; 49:e11–e17 [View Article]
     [Google Scholar]
  5. Chagas-Neto TC, Chaves GM, Melo ASA, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47:1074–1081 [View Article][PubMed]
     [Google Scholar]
  6. Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 2008; 36:68–70 [View Article][PubMed]
     [Google Scholar]
  7. Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol 2010; 84:441–447 [View Article][PubMed]
     [Google Scholar]
  8. Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol 2008; 25:221–225[PubMed]
     [Google Scholar]
  9. Tokimatsu I, Kushima H, Hashinaga K, Umeki K, Ohama M et al. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Int J Antimicrob Agents 2007; 29:84–88 [View Article][PubMed]
     [Google Scholar]
  10. Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T et al. Multidrug-Resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39:4420–4425 [View Article][PubMed]
     [Google Scholar]
  11. Oliveira dos Santos C, Zijlstra JG, Porte RJ, Kampinga GA, van Diepeningen AD et al. Emerging pan-resistance in Trichosporon species: a case report. BMC Infect Dis 2016; 16:148 [View Article][PubMed]
     [Google Scholar]
  12. Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA et al. Escmid and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 2014; 20:76–98 [View Article][PubMed]
     [Google Scholar]
  13. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV et al. Efflux-Mediated antifungal drug resistance. Clin Microbiol Rev 2009; 22:291–321 [View Article][PubMed]
     [Google Scholar]
  14. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2:73–85 [View Article][PubMed]
     [Google Scholar]
  15. Brilhante RSN, Paiva MAN, Sampaio CMS, Castelo-Branco D, Teixeira CEC et al. Azole resistance in Candida spp. isolated from Catú lake, Ceará, Brazil: an efflux-pump-mediated mechanism. Braz J Microbiol Publ Braz Soc Microbiol 2016; 47:33–38 [View Article]
     [Google Scholar]
  16. Sionov E, Lee H, Chang YC, Kwon-Chung KJ. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 2010; 6:e1000848 [View Article][PubMed]
     [Google Scholar]
  17. Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E et al. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans . PLoS One 2012; 7:e33022 [View Article][PubMed]
     [Google Scholar]
  18. Sugita T, Nishikawa A, Shinoda T. Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J Clin Microbiol 1998; 36:1458–1460 [View Article][PubMed]
     [Google Scholar]
  19. Chagas-Neto TC, Chaves GM, Melo ASA, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47:1074–1081 [View Article][PubMed]
     [Google Scholar]
  20. Guo L-N, Xiao M, Kong F, Chen SC-A, Wang H et al. Three-Locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol 2011; 49:3805–3811 [View Article][PubMed]
     [Google Scholar]
  21. Abbes S, Sellami H, Sellami A, Makni F, Mahfoudh N et al. Microsatellite analysis and susceptibility to FCZ of Candida glabrata invasive isolates in Sfax Hospital, Tunisia. Med Mycol 2011; 49:10–15 [View Article][PubMed]
     [Google Scholar]
  22. Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA et al. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Clin Microbiol Infect 2019; 25:909.e1–90909 [View Article][PubMed]
     [Google Scholar]
  23. Montoya AM, Elizondo-Zertuche M, Treviño-Rangel RdeJ, Becerril-García M, González GM. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients. Rev Iberoam Micol 2018; 35:22–26 [View Article][PubMed]
     [Google Scholar]
  24. Yang Y-L, Liu Y-W, Chen H-T, Tsai M-S, Chu W-L et al. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan. Med Mycol 2013; 51:880–883 [View Article][PubMed]
     [Google Scholar]
  25. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H et al. Results from the ARTEMIS disk global antifungal surveillance study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2009; 47:117–123 [View Article][PubMed]
     [Google Scholar]
  26. Rastogi V, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A et al. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India. Mycoses 2016; 59:528–534 [View Article][PubMed]
     [Google Scholar]
  27. Lemes RML, Lyon JP, Moreira LM, de Resende MA. Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol 2010; 41:310–315 [View Article][PubMed]
     [Google Scholar]
  28. Abbes S, Mary C, Sellami H, Michel-Nguyen A, Ayadi A et al. Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata. Front Cell Infect Microbiol 2013; 3:74 [View Article][PubMed]
     [Google Scholar]
  29. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 2009; 5:e1000268 [View Article][PubMed]
     [Google Scholar]
  30. Vermitsky J-P, Earhart KD, Smith WL, Homayouni R, Edlind TD et al. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 2006; 61:704–722 [View Article][PubMed]
     [Google Scholar]
  31. Tsai H-F, Krol AA, Sarti KE, Bennett JE. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Chemother 2006; 50:1384–1392 [View Article][PubMed]
     [Google Scholar]
  32. Frade JP, Warnock DW, Arthington-Skaggs BA. Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J Clin Microbiol 2004; 42:2085–2093 [View Article][PubMed]
     [Google Scholar]
  33. Albertson GD, Niimi M, Cannon RD, Jenkinson HF. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996; 40:2835–2841 [View Article][PubMed]
     [Google Scholar]
  34. Basso LR, Gast CE, Bruzual I, Wong B. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans . J Antimicrob Chemother 2015; 70:1396–1407 [View Article][PubMed]
     [Google Scholar]
  35. Kushima H, Tokimatsu I, Ishii H, Kawano R, Shirai R et al. Cloning of the lanosterol 14-α-demethylase (ERG11) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii . FEMS Yeast Res 2012; 12:662–667 [View Article][PubMed]
     [Google Scholar]
  36. Kushima H, Tokimatsu I, Ishii H, Kawano R, Watanabe K et al. A new amino acid substitution at G150S in lanosterol 14-α demethylase (ERG11 protein) in Multi-azole-resistant Trichosporon asahii . Med Mycol J 2017; 58:E23–E28 [View Article][PubMed]
     [Google Scholar]
  37. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49:S90–S95 [View Article][PubMed]
     [Google Scholar]
  38. Morio F, Loge C, Besse B, Hennequin C, Le Pape P. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 2010; 66:373–384 [View Article][PubMed]
     [Google Scholar]
  39. Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ et al. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem 2017; 292:6728–6743 [View Article][PubMed]
     [Google Scholar]
  40. Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40:1826–1830 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001236
Loading
Implication of efflux pumps and ERG11 genes in resistance of clinical Trichosporon asahii isolates to fluconazole
J. Med. Microbiol. 70, 001236 (2021); https://doi.org/10.1099/jmm.0.001236
/content/journal/jmm/10.1099/jmm.0.001236
/content/journal/jmm/10.1099/jmm.0.001236
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error